$256 Million is the total value of Tri Locum Partners LP's 37 reported holdings in Q1 2022. The portfolio turnover from Q4 2021 to Q1 2022 was 107.3% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| JAZZ | New | JAZZ PHARMACEUTICALS PLC | $20,343,000 | – | 130,678 | +100.0% | 7.95% | – |
| PTGX | Buy | PROTAGONIST THERAPEUTICS INC | $18,216,000 | +69.7% | 769,250 | +145.0% | 7.12% | +68.3% |
| REGN | New | REGENERON PHARMACEUTICALS | $15,000,000 | – | 21,477 | +100.0% | 5.86% | – |
| HZNP | New | HORIZON THERAPEUTICS PUB L | $13,923,000 | – | 132,332 | +100.0% | 5.44% | – |
| CLDX | New | CELLDEX THERAPEUTICS INC NEW | $13,056,000 | – | 383,319 | +100.0% | 5.10% | – |
| EW | Sell | EDWARDS LIFESCIENCES CORP | $12,571,000 | -34.2% | 106,790 | -27.5% | 4.91% | -34.7% |
| KZR | Sell | KEZAR LIFE SCIENCES INC | $12,148,000 | -0.8% | 730,897 | -0.2% | 4.74% | -1.6% |
| LLY | Sell | LILLY ELI & CO | $11,916,000 | -45.1% | 41,610 | -47.0% | 4.66% | -45.5% |
| ARGX | Sell | ARGENX SEsponsored adr | $11,313,000 | -33.2% | 35,880 | -25.8% | 4.42% | -33.7% |
| ACET | Sell | ADICET BIO INC | $10,449,000 | +2.4% | 523,256 | -10.3% | 4.08% | +1.6% |
| INBX | Buy | INHIBRX INC | $9,062,000 | -2.7% | 406,733 | +90.8% | 3.54% | -3.4% |
| BMY | New | BRISTOL-MYERS SQUIBB CO | $8,969,000 | – | 122,817 | +100.0% | 3.50% | – |
| ISEE | New | IVERIC BIO INC | $8,489,000 | – | 504,371 | +100.0% | 3.32% | – |
| Buy | STEVANATO GROUP S P A | $8,388,000 | +64.8% | 416,920 | +83.9% | 3.28% | +63.6% | |
| SKIN | Sell | THE BEAUTY HEALTH COMPANY | $8,327,000 | -31.9% | 493,301 | -2.6% | 3.25% | -32.5% |
| EVH | Buy | EVOLENT HEALTH INCcl a | $7,477,000 | +20.1% | 231,499 | +2.8% | 2.92% | +19.1% |
| EXEL | New | EXELIXIS INC | $7,460,000 | – | 329,068 | +100.0% | 2.91% | – |
| CCXI | Sell | CHEMOCENTRYX INC | $7,429,000 | -53.2% | 296,327 | -32.1% | 2.90% | -53.6% |
| FATE | Buy | FATE THERAPEUTICS INC | $7,380,000 | -11.2% | 190,345 | +34.0% | 2.88% | -11.9% |
| BLU | Buy | BELLUS HEALTH INC NEW | $6,946,000 | -11.6% | 1,009,615 | +3.5% | 2.71% | -12.3% |
| ALDX | New | ALDEYRA THERAPEUTICS INC | $6,434,000 | – | 1,447,445 | +100.0% | 2.51% | – |
| BHVN | Buy | BIOHAVEN PHARMACTL HLDG CO L | $6,136,000 | +82.9% | 51,750 | +112.6% | 2.40% | +81.5% |
| RXDX | New | PROMETHEUS BIOSCIENCES INC | $5,629,000 | – | 149,066 | +100.0% | 2.20% | – |
| BNTX | New | BIONTECH SEsponsored ads | $5,274,000 | – | 30,923 | +100.0% | 2.06% | – |
| RVMD | New | REVOLUTION MEDICINES INC | $4,348,000 | – | 170,455 | +100.0% | 1.70% | – |
| TCDA | Buy | TRICIDA INC | $3,530,000 | +117.5% | 429,383 | +152.9% | 1.38% | +115.8% |
| XFOR | Buy | X4 PHARMACEUTICALS INC | $3,006,000 | -16.9% | 1,717,589 | +8.8% | 1.17% | -17.6% |
| LPTX | New | LEAP THERAPEUTICS INC | $2,112,000 | – | 1,206,897 | +100.0% | 0.82% | – |
| FEMY | Sell | FEMASYS INC | $199,000 | -65.0% | 87,952 | -39.6% | 0.08% | -65.2% |
| NLY | New | ANNALY CAPITAL MANAGEMENT IN | $113,000 | – | 16,059 | +100.0% | 0.04% | – |
| SPNT | New | SIRIUSPOINT LTD | $86,000 | – | 11,488 | +100.0% | 0.03% | – |
| GNW | New | GENWORTH FINL INC | $58,000 | – | 15,436 | +100.0% | 0.02% | – |
| CASA | New | CASA SYS INC | $51,000 | – | 11,351 | +100.0% | 0.02% | – |
| UWMC | New | UWM HOLDINGS CORPORATION | $47,000 | – | 10,330 | +100.0% | 0.02% | – |
| INSG | New | INSEEGO CORP | $44,000 | – | 10,831 | +100.0% | 0.02% | – |
| AVAH | New | AVEANNA HEALTHCARE HLDGS INC | $37,000 | – | 10,848 | +100.0% | 0.01% | – |
| SKLZ | New | SKILLZ INC | $34,000 | – | 11,275 | +100.0% | 0.01% | – |
| AWH | Exit | ASPIRA WOMENS HEALTH INC | $0 | – | -10,876 | -100.0% | -0.01% | – |
| ATHX | Exit | ATHERSYS INC NEW | $0 | – | -19,449 | -100.0% | -0.01% | – |
| DRRX | Exit | DURECT CORP | $0 | – | -26,387 | -100.0% | -0.01% | – |
| XENE | Exit | XENON PHARMACEUTICALS INC | $0 | – | -25,043 | -100.0% | -0.31% | – |
| ACRS | Exit | ACLARIS THERAPEUTICS INC | $0 | – | -55,433 | -100.0% | -0.32% | – |
| SRRK | Exit | SCHOLAR ROCK HLDG CORP | $0 | – | -40,571 | -100.0% | -0.40% | – |
| VIR | Exit | VIR BIOTECHNOLOGY INCput | $0 | – | -30,000 | -100.0% | -0.49% | – |
| CANO | Exit | CANO HEALTH INC | $0 | – | -141,508 | -100.0% | -0.50% | – |
| AMWL | Exit | AMERICAN WELL CORPcl a | $0 | – | -224,876 | -100.0% | -0.54% | – |
| ITCI | Exit | INTRA-CELLULAR THERAPIES INC | $0 | – | -26,177 | -100.0% | -0.54% | – |
| ONEM | Exit | 1LIFE HEALTHCARE INC | $0 | – | -84,748 | -100.0% | -0.59% | – |
| NVAX | Exit | NOVAVAX INCcall | $0 | – | -10,600 | -100.0% | -0.60% | – |
| CYTK | Exit | CYTOKINETICS INC | $0 | – | -33,379 | -100.0% | -0.60% | – |
| RAPT | Exit | RAPT THERAPEUTICS INC | $0 | – | -48,141 | -100.0% | -0.70% | – |
| SKIN | Exit | THE BEAUTY HEALTH COMPANYcall | $0 | – | -74,000 | -100.0% | -0.70% | – |
| ABMD | Exit | ABIOMED INC | $0 | – | -5,169 | -100.0% | -0.73% | – |
| ZNTL | Exit | ZENTALIS PHARMACEUTICALS INC | $0 | – | -23,632 | -100.0% | -0.78% | – |
| CTLT | Exit | CATALENT INC | $0 | – | -23,700 | -100.0% | -1.19% | – |
| Exit | SCIENCE 37 HOLDINGS INC | $0 | – | -271,159 | -100.0% | -1.33% | – | |
| LEGN | Exit | LEGEND BIOTECH CORPsponsored ads | $0 | – | -89,840 | -100.0% | -1.65% | – |
| SGEN | Exit | SEAGEN INC | $0 | – | -59,940 | -100.0% | -3.65% | – |
| UTHR | Exit | UNITED THERAPEUTICS CORP DEL | $0 | – | -45,904 | -100.0% | -3.90% | – |
| APLS | Exit | APELLIS PHARMACEUTICALS INC | $0 | – | -318,269 | -100.0% | -5.92% | – |
| ABBV | Exit | ABBVIE INC | $0 | – | -179,950 | -100.0% | -9.59% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-05-16
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| FEMASYS INC | 10 | Q3 2023 | 0.5% |
| REGENERON PHARMACEUTICALS | 9 | Q3 2023 | 13.8% |
| LILLY ELI & CO | 9 | Q2 2023 | 9.5% |
| X4 PHARMACEUTICALS INC | 8 | Q3 2023 | 3.0% |
| XENON PHARMACEUTICALS INC | 8 | Q3 2023 | 2.4% |
| ARGENX SE | 7 | Q3 2023 | 12.8% |
| STEVANATO GROUP S P A | 7 | Q2 2023 | 5.8% |
| PROTAGONIST THERAPEUTICS INC | 7 | Q2 2023 | 7.1% |
| AVADEL PHARMACEUTICALS PLC | 7 | Q3 2023 | 6.4% |
| BELLUS HEALTH INC NEW | 7 | Q3 2022 | 4.3% |
View Tri Locum Partners LP's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| SC 13G | 2023-04-27 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
| 13F-HR | 2022-05-16 |
View Tri Locum Partners LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.